For the Initial Treatment of Venous Thromboembolism - Are All Low-molecular-weight Heparin Compounds the Same?

Author： van der Heijden J.F. Prins M.H. Buller H.R.

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.100, Iss.2, 2000-10, pp. : 121-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-Molecular-Weight Heparin: The Optimal Duration of Prophylaxis Against Postoperative Venous Thromboembolism After Total Hip or Knee Replacement

By Heit J.A.

Thrombosis Research, Vol. 101, Iss. 1, 2001-01 ,pp. : 163-173

Elsevier

Access to resources Recommend Favorite

Low-molecular-weight heparin vs. a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

By Lee A.Y.Y. Levine M.N. Baker R.I. for the Randomized Comparison of Low-Molecular-Weight Heparin vs. Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer CLOT Investigators

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 19-20

Elsevier

Access to resources Recommend Favorite

Prevention of Venous Thromboembolism - Prophylaxis with a low molecular weight heparin (Fragmin)

By Agnelli G. Sonaglia F.

Thrombosis Research, Vol. 97, Iss. 1, 2000-01 ,pp. : 49-62

Elsevier

Access to resources Recommend Favorite

ENOXAPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN SUPPRESSES PROTHROMBIN ACTIVATION MORE EFFECTIVELY THAN UNFRACTIONATED HEPARIN IN PATIENTS TREATED FOR VENOUS THROMBOEMBOLISM

By Grosset A.B. Spiro T.E. Beynon J. Rodgers G.M.

Thrombosis Research, Vol. 86, Iss. 5, 1997-06 ,pp. : 349-354

Elsevier

Access to resources Recommend Favorite

Low-molecular-weight Heparin During Pregnancy

By Bazzan M. Donvito V.

Thrombosis Research, Vol. 101, Iss. 1, 2001-01 ,pp. : 175-186

Elsevier

Access to resources Recommend Favorite